In this regard, we investigated whether LPA3 connected NETs release was associated with thrombosis during sepsis and whether treatment with LPA3 agonist, such as (2S)-1-oleoyl-2-methylglycero-3-phosphothionate (OMPT) could improve sepsis outcomes. This evidence concerns the gene LPAR3 and Venous thrombosis.